Long-Term Outcomes of Continuous Intrathecal Baclofen Infusion for Treatment of Spasticity: A Prospective Multicenter Follow-Up Study
Authors:
- Nicoline BeersenNBNicoline Beersen
- W. Ken RedekopWRW. Ken Redekop
- Niek S. KlazingaNKNiek S. Klazinga
- 1 July 2008
- journal article
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 11 (3) , 227-236
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal originJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patientsSpinal Cord, 2004
- Developing a National Continuous Quality Improvement System for Neuromodulation Treatment in the NetherlandsThe Joint Commission Journal on Quality and Safety, 2004
- Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthoodActa Neurologica Scandinavica, 2002
- Safety and Efficacy of Intrathecal Baclofen Infusion by Implantable Pump for the Treatment of Severe Spinal Spasticity: A Spanish Multicenter StudyNeuromodulation: Technology at the Neural Interface, 2000
- Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patientsJournal of Neurosurgery, 1999
- Quality of Life: Effect of Reduced Spasticity from Intrathecal BaclofenJournal of Neuroscience Nursing, 1998
- Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-upArchives of Physical Medicine and Rehabilitation, 1996
- CONTINUOUS INTRATHECAL BACLOFEN FOR SEVERE SPASTICITYThe Lancet, 1985
- The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureMedical Care, 1981